Primary Site >> Colorectal Cancer

Gene >> ATF6B

Journal: Diagn Mol Pathol. 2012 Mar;21(1):14-23.
Title: KRAS mutation testing in colorectal cancer: comparison of the results obtained using 3 different methods for the analysis of codons G12 and G13.
Author: Bihl, Michel P|Hoeller, Sylvia|Andreozzi, Maria Carla|Foerster, Anja|Rufle, Alexander|Tornillo, Luigi|Terracciano, Luigi
PMID: 22306671
Journal: Eur J Hum Genet. 2013 Dec;21(12):1383-8.
Title: Oncogenic mutations and microsatellite instability phenotype predict specific anatomical subsite in colorectal cancer patients.
Author: Corso, Giovanni|Pascale, Valeria|Flauti, Giuseppe|Ferrara, Francesco|Marrelli, Daniele|Roviello, Franco
PMID: 23572025
Journal: Target Oncol. 2014 Jun;9(2):171-5.
Title: Is availability of anti-EGFR therapy for the colorectal adenocarcinomas showing fascin expression limited?
Author: Kocer, Nazim Emrah|Kayaselcuk, Fazilet
PMID: 23588415
Journal: Diagn Pathol. 2014 Sep 30;9:187.
Title: KRAS and BRAF mutational status in colon cancer from Albanian patients.
Author: Martinetti, Daniela|Costanzo, Rosario|Kadare, Shahin|Alimehmeti, Mehdiu|Colarossi, Cristina|Canzonieri, Vincenzo|Berretta, Massimiliano|Memeo, Lorenzo
PMID: 25267307
Journal: Oncotarget. 2017 Mar 7;8(10):17164-17190.
Title: ATM mutations and E-cadherin expression define sensitivity to EGFR-targeted therapy in colorectal cancer.
Author: Geissler, Anna-Lena|Geissler, Miriam|Kottmann, Daniel|Lutz, Lisa|Fichter, Christiane D|Fritsch, Ralph|Weddeling, Britta|Makowiec, Frank|Werner, Martin|Lassmann, Silke
PMID: 28199979